Anti-Leukemic Effect of DNA Methyltransferase Inhibitor on Cell Lines Derived from Myeloid Leukemia in Down Syndrome

被引：0
|
作者：
Tanaka, Tatsuhiko [1 ]
Kudo, Ko [1 ]
Kanezaki, Rika [1 ]
Kobayashi, Akie [1 ]
Sato, Tomohiko [1 ]
Kamio, Takuya [1 ]
Sasaki, Shinya [1 ]
Toki, Tsutomu [1 ]
Ito, Etsuro [2 ]
Terui, Kiminori [1 ]
机构：
[1] Hirosaki Univ, Dept Pediat, Grad Sch Med, Hirosaki, Aomori, Japan
[2] Hirosaki Univ, Dept Community Med, Grad Sch Med, Hirosaki, Aomori, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS2-7
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia
    Johansson, Patricia
    Dierichs, Laura
    Klein-Hitpass, Ludger
    Bergmann, Anke K.
    Moellmann, Michael
    Menninger, Sascha
    Habenberger, Peter
    Klebl, Bert
    Siveke, Jens T.
    Duehrsen, Ulrich
    Choidas, Axel
    Duerig, Jan
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [22] The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia
    van der Hoorn, MAWG
    van Luxemburg-Heijs, SAP
    van Bergen, CAM
    Bongaerts, R
    Willemze, R
    Falkenburg, JHF
    METHODS, 2003, 31 (02) : 113 - 119
  • [23] Anti-leukemic activity of a novel histone deacetylase inhibitor, CG200745, via induction of mitochondrial dysfunction in acute myeloid leukemia
    Hur, Eun-hye
    Goo, Bon-Kwan
    Kim, Sung-Doo
    Kim, Minhee
    Choi, Yunsuk
    Lee, Kyoo-Hyung
    Lee, Jung-Hee
    Kim, Dae-Young
    Hwang, Jung Jin
    Kim, Choung-Soo
    Ro, Seonggu
    Lee, Je-Hwan
    CANCER RESEARCH, 2012, 72
  • [24] IMMUNOBIOLOGICAL EFFECTS OF NKT CELLS FROM ACUTE MYELOID LEUKEMIA PATIENTS IN A PRE-CLINICAL ANTI-LEUKEMIC TRIAL
    Kim, H. J.
    Choi, J. B.
    Moon, J. H.
    Lee, T. H.
    Kang, H. S.
    Min, W. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 299 - 299
  • [25] Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
    Michallet, Mauricette
    Sobh, Mohamad
    Labussiere, Helene
    Lombard, Christine
    Barraco, Fiorenza
    El-Hamri, Mohamed
    Thomas, Xavier
    Chapuis-Cellier, Colette
    Nicolini, Franck E.
    LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 237 - 240
  • [26] PARP Inhibition with Talazoparib Enhances DNA Damage and Anti-Leukemic Activity of Venetoclax in Preclinical Human Acute Myeloid Leukemia (AML) Models
    Giorgi, Marianna
    Portwood, Scott M.
    Boncek, Marina
    Wang, Eunice S.
    BLOOD, 2021, 138
  • [27] Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia
    Zhou, Qi
    Guan, Yongyu
    Zhao, Pingping
    Chu, Huiyuan
    Xi, Yaming
    TRANSLATIONAL ONCOLOGY, 2025, 52
  • [28] T cells are required for the CMV-induced anti-leukemic effect in patients with acute myeloid leukemia patients after transplant
    Elmaagacli, A. H.
    Koldehoff, M.
    Sonius, M.
    Steckel, N. K.
    Trenschel, R.
    Ditschkowski, M.
    Gromke, T.
    Ross, R. S.
    Ottinger, H.
    Beelen, D.
    ONKOLOGIE, 2012, 35 : 173 - 173
  • [29] DECITABINE ENHANCES CYTOTOXIC EFFECT OF OTHER ANTI-LEUKEMIC AGENTS SYNERGISTICALLY IN ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINE
    Sakaguchi, K.
    Takahashi, H.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S340 - S340
  • [30] Anti-Leukemic Activity of PIK-75, a PI3-Kinase p110α Selective Inhibitor, In Acute Myeloid Leukemia
    Vergez, Francois
    Sarry, Jean-Emmanuel
    Gallay, Nathalie
    Fialin, Camille
    Scotland, Sarah
    Demur, Cecile
    Shepherd, Peter
    Danet-Begnoyer, Gwenn-ael
    Kruczynski, Anna
    Payrastre, Bernard
    Manenti, Stephane
    Recher, Christian
    BLOOD, 2010, 116 (21) : 288 - 288
12345